Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycotoxins are chemically diverse toxic secondary metabolites produced by filamentous fungi such as Aspergillus, Fusarium, Penicillium, and Claviceps[1][3][5][7]. Hundreds of types exist, but a small subset cause the greatest risk to human and animal health, notably aflatoxins, ochratoxin A, fumonisins, zearalenone, and deoxynivalenol[1][3][5][9]. These compounds can contaminate crops and foodstuffs, especially under warm, humid conditions, and are chemically stable, often surviving food processing[9]. Their biological effects vary: aflatoxins are strongly carcinogenic and hepatotoxic; ochratoxin A is nephrotoxic and carcinogenic; deoxynivalenol is immunosuppressive and causes protein synthesis inhibition[6]. Mycotoxins do not serve as druggable targets in the sense of traditional pharmacology; rather, they are hazardous environmental agents, and research is focused on detection, detoxification, and mitigation of their effects on health[1][10]. In summary, mycotoxins refer to a broad chemical class of toxic fungal metabolites, not an individual target molecule or protein. Therefore, most fields above are either inapplicable or reflect the broad toxicological relevance, not target-drug interaction.
mycotoxins act via direct toxicity, not as a modulated pathway; some cause DNA adduction, inhibition of protein synthesis, apoptosis induction, endocrine disruption, ROS generation, ribotoxic stress
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycotoxin.